Kimberly Manhard insider trades: Inhibrx Biosciences (INBX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kimberly reports to the SEC
Open-market buys and sales
51 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | INBX | ↓ Sell | 1,500 | $109.03 | $164K | Kimberly Joan Manhard Revocable Trust, | Sep 15, 2026 (0d) |
| Aug 28, 2024 | INBX | ↑ Buy | 10,000 | $13.98 | $140K | Kimberly Joan Manhard Revocable Trust, | Aug 30, 2024 (2d) |
| May 3, 2022 | HRTX | ↓ Sell | 1,504 | $4.76 | $7K | Direct | May 4, 2022 (1d) |
| May 3, 2021 | HRTX | ↓ Sell | 1,529 | $17.66 | $27K | Direct | May 4, 2021 (1d) |
| Dec 22, 2020 | HRTX | ↓ Sell | 10,000 | $20.00 | $200K | Direct | Dec 23, 2020 (1d) |
| May 1, 2020 | HRTX | ↓ Sell | 1,158 | $13.97 | $16K | Direct | May 1, 2020 (0d) |
| Nov 29, 2019 | HRTX | ↓ Sell | 24,000 | $26.00 | $624K | Direct | Dec 3, 2019 (4d) |
| May 1, 2019 | HRTX | ↓ Sell | 1,109 | $18.86 | $21K | Direct | May 2, 2019 (1d) |
| Nov 2, 2018 | HRTX | ↓ Sell | 494 | $30.62 | $15K | Direct | Nov 2, 2018 (0d) |
| Oct 1, 2018 | HRTX | ↓ Sell | 6,000 | $32.07 | $192K | Direct | Oct 2, 2018 (1d) |
| Jul 2, 2018 | HRTX | ↓ Sell | 6,000 | $37.53 | $225K | Direct | Jul 3, 2018 (1d) |
| Mar 19, 2018 | HRTX | ↓ Sell | 18,000 | $30.00 | $540K | Direct | Mar 19, 2018 (0d) |
| Jan 10, 2018 | HRTX | ↓ Sell | 7,584 | $20.00 | $152K | Direct | Jan 12, 2018 (2d) |
| Apr 24, 2017 | HRTX | ↓ Sell | 21,542 | $15.33 | $330K | Direct | Apr 24, 2017 (0d) |
| Jun 2, 2015 | HRTX | ↓ Sell | 13,208 | $23.09 | $305K | Direct | Jun 3, 2015 (1d) |
| Jun 19, 2012 | RDEA | ↓ Sell | 12,829 | $31.96 | $410K | Direct | Jun 20, 2012 (1d) |
| May 29, 2012 | RDEA | ↓ Sell | 5,000 | $31.89 | $159K | Direct | May 29, 2012 (0d) |
| Apr 30, 2012 | RDEA | ↓ Sell | 5,000 | $31.82 | $159K | Direct | Apr 30, 2012 (0d) |
| Mar 28, 2012 | RDEA | ↓ Sell | 5,000 | $22.65 | $113K | Direct | Mar 29, 2012 (1d) |
| Feb 28, 2012 | RDEA | ↓ Sell | 5,000 | $20.99 | $105K | Direct | Feb 29, 2012 (1d) |
| Jan 30, 2012 | RDEA | ↓ Sell | 5,000 | $18.01 | $90K | Direct | Jan 31, 2012 (1d) |
| Dec 28, 2011 | RDEA | ↓ Sell | 5,000 | $16.97 | $85K | Direct | Dec 29, 2011 (1d) |
| Nov 28, 2011 | RDEA | ↓ Sell | 5,000 | $17.67 | $88K | Direct | Nov 29, 2011 (1d) |
| Oct 28, 2011 | RDEA | ↓ Sell | 5,000 | $21.27 | $106K | Direct | Oct 28, 2011 (0d) |
| Sep 28, 2011 | RDEA | ↓ Sell | 5,000 | $16.28 | $81K | Direct | Sep 30, 2011 (2d) |
| Aug 29, 2011 | RDEA | ↓ Sell | 5,000 | $15.13 | $76K | Direct | Aug 30, 2011 (1d) |
| Jul 28, 2011 | RDEA | ↓ Sell | 5,000 | $23.56 | $118K | Direct | Jul 29, 2011 (1d) |
| Jun 28, 2011 | RDEA | ↓ Sell | 5,000 | $25.37 | $127K | Direct | Jun 29, 2011 (1d) |
| May 31, 2011 | RDEA | ↓ Sell | 5,000 | $24.83 | $124K | Direct | Jun 1, 2011 (1d) |
| Apr 28, 2011 | RDEA | ↓ Sell | 5,000 | $27.80 | $139K | Direct | Apr 29, 2011 (1d) |
| Mar 28, 2011 | RDEA | ↓ Sell | 5,000 | $27.76 | $139K | Direct | Mar 29, 2011 (1d) |
| Feb 28, 2011 | RDEA | ↓ Sell | 5,000 | $26.50 | $132K | Direct | Mar 1, 2011 (1d) |
| Jan 28, 2011 | RDEA | ↓ Sell | 5,000 | $27.38 | $137K | Direct | Jan 28, 2011 (0d) |
| Dec 28, 2010 | RDEA | ↓ Sell | 5,000 | $26.62 | $133K | Direct | Dec 30, 2010 (2d) |
| Nov 29, 2010 | RDEA | ↓ Sell | 5,000 | $22.24 | $111K | Direct | Nov 30, 2010 (1d) |
| Oct 28, 2010 | RDEA | ↓ Sell | 5,000 | $21.03 | $105K | Direct | Nov 1, 2010 (4d) |
| Sep 28, 2010 | RDEA | ↓ Sell | 5,000 | $23.03 | $115K | Direct | Sep 30, 2010 (2d) |
| Aug 30, 2010 | RDEA | ↓ Sell | 8,968 | $20.00 | $179K | Direct | Sep 1, 2010 (2d) |
| Jul 28, 2010 | RDEA | ↓ Sell | 2,500 | $19.44 | $49K | Direct | Jul 29, 2010 (1d) |
| Jun 28, 2010 | RDEA | ↓ Sell | 2,500 | $21.92 | $55K | Direct | Jun 29, 2010 (1d) |
| May 28, 2010 | RDEA | ↓ Sell | 2,500 | $24.97 | $62K | Direct | Jun 1, 2010 (4d) |
| Apr 28, 2010 | RDEA | ↓ Sell | 2,500 | $25.16 | $63K | Direct | Apr 29, 2010 (1d) |
| Mar 29, 2010 | RDEA | ↓ Sell | 2,500 | $18.72 | $47K | Direct | Mar 30, 2010 (1d) |
| Feb 26, 2010 | RDEA | ↓ Sell | 2,500 | $14.28 | $36K | Direct | Mar 1, 2010 (3d) |
| Jan 28, 2010 | RDEA | ↓ Sell | 2,500 | $14.54 | $36K | Direct | Jan 29, 2010 (1d) |
| Dec 28, 2009 | RDEA | ↓ Sell | 2,500 | $14.49 | $36K | Direct | Dec 29, 2009 (1d) |
| Nov 27, 2009 | RDEA | ↓ Sell | 2,500 | $14.44 | $36K | Direct | Dec 1, 2009 (4d) |
| Oct 28, 2009 | RDEA | ↓ Sell | 2,500 | $14.20 | $36K | Direct | Oct 29, 2009 (1d) |
| Sep 28, 2009 | RDEA | ↓ Sell | 2,500 | $19.10 | $48K | Direct | Sep 29, 2009 (1d) |
| Aug 28, 2009 | RDEA | ↓ Sell | 2,500 | $18.39 | $46K | Direct | Aug 31, 2009 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other INBX insiders
Open-market trades in the last 12 months
About Kimberly Manhard's insider trades
Kimberly Manhard is a director at Inhibrx Biosciences (INBX). Since May 19, 2009, Kimberly has reported 1 open-market purchase worth $140K and 50 sales worth $6.7M on SEC Form 4. In the last 12 months: 1 sale ($164K).
Their filings also include option exercises (54 filings), grants and awards (26 filings), shares withheld for taxes (10 filings), other transactions (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every INBX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.